Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 980 of 1,261

  1. US 7842798

    Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  2. US 7842819

    Derivatives for modulation of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  3. US 7842704

    Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  4. US 7842701

    Pyrazoloquinolone derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  5. US 7842717

    DNT-maleate and methods of preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  6. US 7842706

    Pharmaceutical composition

    Takeda Pharmaceutical Company Limited · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  7. US 7842686

    CGRP receptor antagonists

    Vertex Pharmaceuticals Incorporated · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  8. US 7842729

    Anti tubercular drug: compositions and methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

  9. US 7838691

    Palmerolides: methods of preparation and derivatives thereof

    The Board of Regents of the University of Texas System · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  10. US 7838531

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  11. US 7838595

    Water-soluble polymer alkanals

    Nektar Therapeutics · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  12. US 7838004

    Method of making a partially hydrolyzed fucoidan composition

    Sakura Properties, LLC · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  13. US 7838491

    Self-assembly and mineralization of peptide-amphiphile nanofibers

    Northwestern University · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  14. US 7838571

    Photopolymers and use in dental restorative materials

    The Regents of the University of Colorado · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  15. US 7838556

    Ethers of 3-hydroxyphenylacetic acid as selective gamma-hydroxybutyric acid receptor ligands

    The Board of Regents of the University of Texas System · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  16. US 7838289

    Assay utilizing multipotent adult stem cells

    Regents of the University of Minnesota · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  17. US 7837999

    Method of increasing muscle mass with IGF-1 fusion polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  18. US 7838216

    Human gene related to but distinct from EGF receptor gene

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  19. US 7838253

    Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)

    The Regents of the University of California · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  20. US 7838511

    Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers

    The Board of Regents of the University of Texas System · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  21. US 7838517

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  22. US 7838535

    Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  23. US 7838562

    Methods of inhibiting vascular permeability and apoptosis

    UNIVERSITY OF CONNECTICUT · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  24. US 7838554

    Dihydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.